Skip to content

A cohort study of oral cancer patients with sarcopenia and inflammatory marker changes and postoperative complications

A cohort study of oral cancer patients with sarcopenia and inflammatory marker changes and postoperative complications

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300072445
Enrollment
Unknown
Registered
2023-06-14
Start date
2023-06-15
Completion date
Unknown
Last updated
2023-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oral cancer

Interventions

sarcopenia
None-sarcopenia :none

Sponsors

Peking University Shenzhen Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Patients who need surgery for oral malignant tumors (including lip cancer, oral cancer and oropharyngeal cancer); (2) The general condition can tolerate major surgery; (3) Age =18 years old; (4) Subjects voluntarily joined the study, signed written informed consent, and had good compliance and cooperated with the follow-up;

Exclusion criteria

Exclusion criteria: (1) Patients with other malignant tumors at the same time; (2) The patient is accompanied by any unstable systemic diseases, including but not limited to: severe infection, uncontrolled diabetes, unstable angina pectoris, cerebrovascular accident or transient cerebral ischemia, myocardial infarction, congestive heart failure, severe arrhythmia requiring medical treatment, liver, kidney or metabolic diseases, which may lead to the interruption of treatment or limit the compliance with the research requirements; (3) Patients who have severe systemic or local infection within 2 weeks before operation and need anti-inflammatory treatment before operation; (4) Patients with preoperative history of radiotherapy and chemotherapy; (5) The researcher thinks that it is not suitable to participate in the trial for other reasons or any situation that may interfere with the patient's participation in the study.

Design outcomes

Primary

MeasureTime frame
Sarcopenia;

Secondary

MeasureTime frame
postoperative hospital stay;Disease-Free Survival;Over-all Survival;

Countries

China

Contacts

Public ContactLin Bo

Peking University Shenzhen Hospital

amber001@pku.org.cn+86 159 8959 6586

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026